# The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-effects-of-switching-daily-teriparatide-to-oral-bisphosphonates-or-denosumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kosuke Ebina,Jun Hashi­moto,Masafumi Kashii,Makoto Hirao,Shoichi Kaneshiro,Takaaki Noguchi,Yasunori Tsukamoto,Hideki Yoshikawa |
| Citations | 67 |
| DOI | 10.1007/s00774-015-0731-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://hdl.handle.net/11094/93257 |
| OpenAlex ID | https://openalex.org/W2258162599 |
| PMID | 26762133 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Masafumi Kashii](https://scholariq.org/researchers/masafumi-kashii/)

## Paper journal

- [Journal of Bone and Mineral Metabolism](https://scholariq.org/journals/journal-of-bone-and-mineral-metabolism/)

## Paper primary topic

- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)

## Paper topics

- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.